Eric Salzman: Question 14, given we are not controlled shareholders and of these portfolio companies, can we drive monetization time lines? That has been a — it’s a great question. It’s one that we’ve been working with for the last 3 years. And what I can say is that in each of our companies, we have very good alignment in terms of among ourselves and management and the other investors in terms of how long we want to be in the investment, right? So other — our co-investors are similarly — these are — the whole periods have been long, relatively long. So there’s alignment to exit the decision to exit is really less of a — or people or the management and the stakeholders to align to exit. It’s really more of the opportunity availability, valuation, does the company — is the company putting up the types of metrics needed to attract buyers in a reasonable way?
So that’s — it’s less of the — an issue about how to drive monetization time lines because there’s alignment.
Mark Herndon: And, Eric [indiscernible] have another question, come in about the range of proceeds, particularly the low end of the proceeds with respect to InfoBionic moving into Bucket 1. So — and I will tell you, I mean, we made that the full range estimate last quarter, right, when things were in flux with the one company. And we updated it again this quarter [indiscernible] in a bottoms up analysis. And as you might expect, there’s not a perfect level on any of these. And things vary within the portfolio even from the estimates. And we just — we still have come up with the same range. It just has not — moving InfoBionic in there. Yes, I would say they give you and more confidence at one end of the range, but it’s not something in and of itself, it’s going to move you from — move the range significantly or within the range significantly.
Eric Salzman: And I’ll add to that — and I’ll add to that. Last — when we did this analysis last quarter, we had some probability weighting for InfoBionic achieving a recap and a set of outcomes. So it wasn’t necessarily in a 0 last quarter and a big number this quarter. There was a number that reflected the probability of the recap getting done. And the second thing I would say is with a 5% ownership stake, which is what we have — it doesn’t — it moves the needle given where our stock price is and what we are trying to do, but it doesn’t swing as much as some of the other companies will have a larger ownership stakes.
Mark Herndon: [Indiscernible] for a second. Operator, were there any other questions on the line?
Operator: We have a question from Sherry Rubinstein, a Private Investor. Please proceed.
Sherry Rubinstein: Am I on?
Mark Herndon: Yes, you are. Hi. How are you?
Sherry Rubinstein: Oh, hi. I’m really new to this. I don’t try to understand. I only have 83 shares. So I’ll be cashed out. What does that mean exactly?
Mark Herndon: If you end up being cashed out, then you would — your brokerage account would simply receive a check cash and the price out run in the proxy of $1.65 per share.
Sherry Rubinstein: $1.65 per share. Because right now, it’s only $0.98.
Mark Herndon: Correct. Yes. The cash out price is at a premium to today’s traded price.
Sherry Rubinstein: So am I best to wait for until you cash me out or …
Mark Herndon: Well, I need to avoid giving individual investment advice.
Sherry Rubinstein: Okay. I just — so I should have to ask my broker that. So right now, if I sold it, I would be getting $0.98, if I wait when are you cashing out?
Mark Herndon: If this transaction is approved by shareholders, we would expect it to occur around December 15.
Sherry Rubinstein: December 15. Okay. So possibly then I could get $1.65 a share if I just wait until then. Is that correct?
